Shares of Apollo Medical Holdings Inc (NASDAQ:AMEH) have earned an average broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation.
Brokers have set a 1-year consensus target price of $25.00 for the company, according to Zacks. Zacks has also given Apollo Medical an industry rank of 83 out of 256 based on the ratings given to related companies.
A number of brokerages have recently issued reports on AMEH. TheStreet downgraded The Providence Service from a “b-” rating to a “c+” rating in a research report on Friday, June 28th. ValuEngine downgraded Universal Electronics from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 6th. Finally, Zacks Investment Research downgraded Hanger from a “hold” rating to a “sell” rating in a research report on Tuesday, May 28th.
Shares of AMEH traded up $0.01 during trading hours on Friday, reaching $15.33. 26,924 shares of the company’s stock traded hands, compared to its average volume of 82,353. The company has a market capitalization of $547.97 million, a PE ratio of 52.86, a PEG ratio of 4.51 and a beta of -0.78. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.00 and a current ratio of 2.00. The firm’s 50 day simple moving average is $15.65. Apollo Medical has a 12 month low of $13.36 and a 12 month high of $28.67.
In other news, CFO Eric Chin bought 2,040 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was bought at an average price of $14.72 per share, for a total transaction of $30,028.80. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Kenneth T. Sim bought 6,996 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was purchased at an average price of $14.50 per share, with a total value of $101,442.00. The disclosure for this purchase can be found here. Insiders purchased a total of 26,036 shares of company stock valued at $375,418 in the last 90 days. 16.88% of the stock is currently owned by corporate insiders.
A number of large investors have recently added to or reduced their stakes in the stock. Great West Life Assurance Co. Can purchased a new position in Apollo Medical in the 4th quarter worth approximately $99,000. BlackRock Inc. increased its stake in Apollo Medical by 8.7% in the 4th quarter. BlackRock Inc. now owns 353,218 shares of the company’s stock worth $7,012,000 after purchasing an additional 28,411 shares during the period. Northern Trust Corp increased its stake in Apollo Medical by 33.2% in the 4th quarter. Northern Trust Corp now owns 111,883 shares of the company’s stock worth $2,221,000 after purchasing an additional 27,894 shares during the period. Strs Ohio increased its stake in Apollo Medical by 98.6% in the 1st quarter. Strs Ohio now owns 14,300 shares of the company’s stock worth $261,000 after purchasing an additional 7,100 shares during the period. Finally, Manchester Financial Inc. increased its stake in Apollo Medical by 18.5% in the 1st quarter. Manchester Financial Inc. now owns 92,621 shares of the company’s stock worth $1,697,000 after purchasing an additional 14,453 shares during the period. Institutional investors own 6.67% of the company’s stock.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
See Also: What is a Candlestick Chart?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.